Keytruda

3 results

Merck’s cancer drug Keytruda booked sales of more than $2 billion for the first time in the fourth quarter. Photograph: Brendan McDermid/Reuters

Merck’s cancer immumotherapy Keytruda booked sales of more than $2 billion in a quarter for the first time, exceeding Wall Street’s lofty estimates an(...)

Even though they are exported from Ireland for use in other European countries, five drugs manufactured in Ireland for the treatment of cancer and heart disease are not sanctioned for use here.

Five drugs manufactured in Ireland for the treatment of cancer and heart disease are not sanctioned for use here, even though they are exported from I(...)

Merck reported a better-than-expected first-quarter profit on Tuesday, helped by a rise of more than 150 per cent in sales of cancer drug Keytruda.

Drugmaker Merck reported a better-than-expected first-quarter profit on Tuesday, helped by a rise of more than 150 per cent in sales of cancer drug Ke(...)